Clinical Trials Browser

Diarrhea × Erlotinib Hydrochloride × Clear all

NCT02080078 2019-05-03

A Phase I Dose Escalation Study of Erlotinib in Combination With Theophylline

Phase 1 Terminated

Carcinoma, Non-Small-Cell Lung, Diarrhea